Orchid Wins $4.8M Government Contract to Develop Oligo Technology | GenomeWeb

NEW YORK, Sept. 28 - Orchid BioSciences has won a three-year, $4.8 million contract from the Office of Special Technology of the US Defense Advanced Research Projects Agency to develop technology for microfluidic-enabled DNA synthesis that can produce “significant quantities” of long oligos, the company said on Friday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.